A nurse reported a patient on peritoneal dialysis (pd) therapy was hospitalized for peritonitis.There were no reported allegations that the event was related to fresenius products.In additional follow-up, the patient¿s pd nurse reported that on (b)(6) 2024 the patient was hospitalized with symptoms of abdominal pain.During hospitalization, the patient had a pd culture obtained which yielded an elevated white blood cell (wbc) count and no organism growth.The patient was initiated on intra-peritoneal (ip) antibiotic therapy with vancomycin and ceftazidime (dosing not provided).On (b)(6) 2024, the patient was discharged and is reportedly recovering from peritonitis event.The patient continues pd with the same cycler, per the nurse.The nurse stated the patient did not have any fluid leaks or any issues with fresenius products in relation to the event.The nurse stated the peritonitis was due to a breach in aseptic technique during the pd exchange.
|